CANY
ALTO icon

Caxton Associates (New York)’s Alto Ingredients ALTO Stock Holding History

Caxton Associates (New York)’s Portfolio ALTO Stock Details ALTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-56,332
Closed -$249K – 459
2023
Q3 		$249K Buy
+56,332
New +$218K 0.03% 331
2022
Q3 		– Sell
-30,222
Closed -$112K – 473
2022
Q2 		$112K Buy
+30,222
New +$158K 0.01% 508
2021
Q1 		– Sell
-16,337
Closed -$89K – 419
2020
Q4 		$89K Buy
+16,337
New +$113K 0.01% 133

Other funds holding ALTO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caxton Associates (New York)'s ALTO Position: Q4 2023 in Review

Caxton Associates (New York) sold out of Alto Ingredients (ALTO) in Q4 2023, closing a stake of 56,332 shares — an estimated $249K sold.

Caxton Associates (New York) first reported a position in ALTO in Q4 2020 and held it in 3 quarters. The position peaked at $249K in Q3 2023. 103 funds tracked by Wall St. Rank hold ALTO as of Q4 2023.

  • Caxton Associates (New York) reported no remaining Alto Ingredients position as of Q4 2023 after selling out during the quarter.
  • Caxton Associates (New York) sold 56,332 Alto Ingredients shares in Q4 2023, an estimated $249K.
  • Caxton Associates (New York) first reported a position in Alto Ingredients in Q4 2020 and held it in 3 quarters.
  • Caxton Associates (New York)'s Alto Ingredients position peaked at $249K in Q3 2023.
  • 103 funds tracked by Wall St. Rank held Alto Ingredients as of Q4 2023.

Based on Caxton Associates (New York)'s 13F filing for Q4 2023, filed 14 Feb 2024.